@tech.eu 1 year ago
French AI biotech unicorn Owkin has launched a €33 million AI-powered precision medicine project for cancer diagnosis and treatment
@tech.eu 1 year ago
Amadeus Capital Partners’ Volker Hirsch joins Medicines Discovery Catapult as Chief Commercial Officer
@techcrunch.com 1 year ago
Nanopath is looking to drastically change medical diagnostics
@techcrunch.com 2 years ago
Sirona Medical Acquires Nines AI’s algorithms to rebuild radiology’s IT from the ground up
@techcrunch.com 2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@techcrunch.com 2 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@techcrunch.com 2 years ago
Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”
@techcrunch.com 3 years ago
Vibrant raises $7.5M for a drug-free mechanical pill to treat constipation
@xconomy.com 3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@tech.eu 3 years ago
Swiss medtech startup Bloom Diagnostics launches new testing system after €10 million Series B
@tech.eu 3 years ago
French medtech company UroMems raises €16 million Series B
@xconomy.com 4 years ago
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening
@xconomy.com 4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com 4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@techcrunch.com 4 years ago
UK biotech startup Mogrify injects $16M to get novel cell therapies to market soon
@xconomy.com 4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further